Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Dydrogesterone

A synthetic progestin developed in the 1950s and in use since 1961, used for menstrual disorders, endometriosis, luteal phase support and, together with oestrogens, in menopausal hormone therapy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?It is made by shining ultraviolet light on progesterone: the result is a 'retrosteroid' with a bent shape, two rings tilted by about 60 degrees, the only one of its kind on the market.

DydrogesteroneGo to the active ingredient →

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.